Curative strategies for high-risk acute promyelocytic leukemia

Current Opinion in Oncology · Published 2025-09-24 · DOI 10.1097/cco.0000000000001171

Authors being retrieved — see the publisher record. https://doi.org/10.1097/cco.0000000000001171

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• State of the art and future directions in the treatment of metastatic adenoid cystic carcinoma · Current Opinion in Oncology · 2025 · Same journal
• High-risk smoldering myeloma – a case for early intervention? · Current Opinion in Oncology · 2025 · Same journal
• Artificial intelligence for systemic therapy selection and prediction of outcomes in advanced gynecological cancers · Current Opinion in Oncology · 2026 · Same journal
• The evolving landscape of bispecific antibodies in the treatment of lung cancer · Current Opinion in Oncology · 2025 · Same journal
• Circulating tumor DNA in human papilloma virus negative head and neck squamous cell carcinoma · Current Opinion in Oncology · 2026 · Same journal
• Immunotherapy in rare histologies of breast cancer: challenges, opportunities, and future perspectives · Current Opinion in Oncology · 2025 · Same journal
• Emerging role of functional imaging in renal cell carcinoma: from morphology to molecular phenotyping with PET/computed tomography · Current Opinion in Oncology · 2026 · Same journal
• Desmoplastic small round cell tumor · Current Opinion in Oncology · 2026 · Same journal
• Conducting clinical trials in supportive and palliative oncology: challenges and opportunities · Current Opinion in Oncology · 2026 · Same journal
• Optimal management of oligometastatic prostate cancer: current state and future directions · Current Opinion in Oncology · 2026 · Same journal